InterCure (INCR) Earnings Analysis
InterCure (INCR) has no confirmed upcoming earnings date. Trailing P/E -4.01.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does INCR next report earnings?
No confirmed upcoming earnings date is currently scheduled for INCR. This page updates as the calendar is published.
INCR earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2025-08-20 | -0.00448 USD | n/a | n/a | n/a |
| 2025-05-01 | -0.00401 USD | n/a | n/a | n/a |
| 2025-04-29 | -0.21682 USD | n/a | n/a | n/a |
| 2024-12-13 | -0.2079 USD | n/a | n/a | n/a |
| 2024-08-30 | 0.00398 USD | n/a | n/a | n/a |
INCR valuation and analyst view
| Trailing P/E | -4.01 |
|---|---|
| Trailing EPS | -0.70453 USD |
| Price / book | 0.36 |
| Dividend yield | 0.00% |
| Market cap | 0.05B |
| Analyst consensus | Buy (1 buy / 0 hold / 0 sell) |
Related research pages
Frequently asked questions
When is InterCure (INCR)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for INCR. This page updates as the calendar is published.
Did INCR beat earnings last quarter?
Consensus estimate data was not available for INCR's 2025-08-20 report.
What is INCR's current P/E ratio and EPS?
INCR trades at a trailing P/E of -4.01 on trailing EPS of -0.7045285004664271 USD.
What do analysts rate INCR?
Analyst consensus is "Buy" across 1 ratings (0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell).